Northwest Bancshares’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $346K | Sell |
5,700
-25
| -0.4% | -$1.46K | 0.07% | 135 |
|
|
2025
Q4 | $309K | Hold |
5,725
| – | – | 0.06% | 141 |
|
|
2025
Q3 | $258K | Hold |
5,725
| – | – | 0.04% | 162 |
|
|
2025
Q2 | $265K | Buy |
5,725
+1,000
| +21% | +$49.1K | 0.05% | 164 |
|
|
2025
Q1 | $288K | Buy |
4,725
+800
| +20% | +$46.6K | 0.05% | 158 |
|
|
2024
Q4 | $222K | Sell |
3,925
-450
| -10% | -$25.1K | 0.04% | 172 |
|
|
2024
Q3 | $226K | Sell |
4,375
-675
| -13% | -$31.7K | 0.04% | 178 |
|
|
2024
Q2 | $210K | Hold |
5,050
| – | – | 0.04% | 176 |
|
|
2024
Q1 | $274K | Hold |
5,050
| – | – | 0.04% | 179 |
|
|
2023
Q4 | $259K | Sell |
5,050
-715
| -12% | -$37.5K | 0.05% | 156 |
|
|
2023
Q3 | $335K | Buy |
5,765
+1,065
| +23% | +$65.3K | 0.06% | 147 |
|
|
2023
Q2 | $301K | Sell |
4,700
-185
| -4% | -$12.4K | 0.05% | 158 |
|
|
2023
Q1 | $339K | Hold |
4,885
| – | – | 0.07% | 145 |
|
|
2022
Q4 | $351K | Sell |
4,885
-1,490
| -23% | -$112K | 0.07% | 144 |
|
|
2022
Q3 | $454K | Sell |
6,375
-10,367
| -62% | -$752K | 0.11% | 125 |
|
|
2022
Q2 | $1.29M | Sell |
16,742
-1,556
| -9% | -$119K | 0.29% | 73 |
|
|
2022
Q1 | $1.34M | Sell |
18,298
-75,132
| -80% | -$5.04M | 0.26% | 80 |
|
|
2021
Q4 | $5.83M | Buy |
93,430
+3,657
| +4% | +$215K | 1.14% | 16 |
|
|
2021
Q3 | $5.31M | Sell |
89,773
-5
| -0% | -$329 | 1.21% | 20 |
|
|
2021
Q2 | $6M | Sell |
89,778
-706
| -0.8% | -$46K | 1.36% | 14 |
|
|
2021
Q1 | $5.71M | Buy |
90,484
+5,800
| +7% | +$361K | 1.35% | 13 |
|
|
2020
Q4 | $5.25M | Buy |
84,684
+7,072
| +9% | +$435K | 1.35% | 16 |
|
|
2020
Q3 | $4.68M | Buy |
77,612
+6,981
| +10% | +$420K | 1.21% | 17 |
|
|
2020
Q2 | $4.15M | Buy |
70,631
+5,432
| +8% | +$325K | 1.13% | 20 |
|
|
2020
Q1 | $3.63M | Sell |
65,199
-729
| -1% | -$44.6K | 1.81% | 13 |
|
|
2019
Q4 | $4.23M | Buy |
65,928
+46,190
| +234% | +$2.65M | 1.63% | 14 |
|
|
2019
Q3 | $1M | Sell |
19,738
-886
| -4% | -$41.6K | 0.41% | 67 |
|
|
2019
Q2 | $935K | Buy |
20,624
+507
| +3% | +$23.6K | 0.39% | 67 |
|
|
2019
Q1 | $960K | Sell |
20,117
-300
| -1% | -$14.9K | 0.41% | 68 |
|
|
2018
Q4 | $1.06M | Sell |
20,417
-300
| -1% | -$16.1K | 0.51% | 63 |
|
|
2018
Q3 | $1.29M | Buy |
20,717
+1,755
| +9% | +$104K | 0.57% | 60 |
|
|
2018
Q2 | $1.05M | Hold |
18,962
| – | – | 0.44% | 65 |
|
|
2018
Q1 | $1.2M | Sell |
18,962
-55
| -0.3% | -$3.54K | 0.49% | 63 |
|
|
2017
Q4 | $1.17M | Buy |
+19,017
| New | +$1.19M | 0.48% | 61 |
|
Other funds holding BMY
VCM
VPM
Northwest Bancshares's BMY Position: Q1 2026 in Review
Northwest Bancshares reduced its Bristol-Myers Squibb (BMY) stake by 0.44% in Q1 2026, selling an estimated $1.46K and leaving 5,700 shares worth $346K. The position accounts for 0.07% of the portfolio, ranked #135.
Northwest Bancshares first reported a position in BMY in Q4 2017 and has held it in 34 quarters since. The position peaked at $6M in Q2 2021. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Northwest Bancshares held 5,700 shares of Bristol-Myers Squibb worth $346K as of Q1 2026.
- Northwest Bancshares sold 25 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.46K.
- Bristol-Myers Squibb made up 0.07% of Northwest Bancshares's portfolio in Q1 2026, its #135 holding.
- Northwest Bancshares first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 34 quarters since.
- Northwest Bancshares's Bristol-Myers Squibb position peaked at $6M in Q2 2021.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Northwest Bancshares's 13F filing for Q1 2026, filed 12 May 2026.